跳至主要内容
临床试验/CTRI/2024/04/065637
CTRI/2024/04/065637尚未招募不适用

Comparative evaluation of Soft tissue changes, pink esthetic scores, marginal bone level and patient reported outcomes on adjunctive use of A-PRF and frozen A-PRF in delayed implant placement – A randomized clinical trial

Dr. Arimanda Prithvi1 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2024年4月24日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
27
试验地点
1
主要终点
1 Papillary height

研究概览

简要总结

The study is to evaluate and compare the pink esthetic scores, peri implant soft tissue changes, marginal bone level ,wound healing, patient satsification and implant stability by adjunctive use of A-PRF and Frozen A-PRF and a total of 27 subjects with mandibular partial edentulous area will be recruited from out patient department of periodontics and implantology and will be assigned into 3 groups of 9 in each where in control group conventional implant placement and approximations of flaps using sutures will be done .In test group 1 conventional implant placement with A-PRF membrane will be placed  and approximations of flaps using sutures will be done.In test group 2 conventional implant placement with Frozen A-PRF membrane will be placed  and approximations of flaps using sutures will be done and in all the three groups Pink Esthetic Score at baseline,1month,3 months ,papillary height, thickness of peri implant mucosa ,width of peri implant mucosa ,peri implant marginal bone loss at baseline,3 months,6months ,implant stability at base line 3 months and wound healing at 14 days,1 month,3 months and patient satisfication questionnaire are evaluated .The data will be analyzed individually for all the patients.There is no conflict of intreset

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 68.00 Year(s)(—)
性别
All

入选标准

  • •1 FMPS, FMBS less than 20% 2 D2,D3 bone 3 Patients requiring implant in mandibular posterior region.

排除标准

  • •1 Patients with platelet disorders (thrombocythemia, thrombocytopenia) 2 Patients under anti- coagulants3 3 Patients with uncontrolled systemic diseases 4 Patients with para functional habits 5 Pregnant and lactating women 6 Patients under chemotherapy.

结局指标

主要结局

1 Papillary height

时间窗: 1 Papillary height and thickness of peri-implant mucosa at baseline,1 month 3 month | 3 Width of peri-implant mucosa at baseline,3months,6months | 4 Peri implant marginal bone loss at baseline 3months 6 months

2 thickness of peri-implant mucosa

时间窗: 1 Papillary height and thickness of peri-implant mucosa at baseline,1 month 3 month | 3 Width of peri-implant mucosa at baseline,3months,6months | 4 Peri implant marginal bone loss at baseline 3months 6 months

3 Width of peri-implant mucosa

时间窗: 1 Papillary height and thickness of peri-implant mucosa at baseline,1 month 3 month | 3 Width of peri-implant mucosa at baseline,3months,6months | 4 Peri implant marginal bone loss at baseline 3months 6 months

4 Peri implant marginal bone loss

时间窗: 1 Papillary height and thickness of peri-implant mucosa at baseline,1 month 3 month | 3 Width of peri-implant mucosa at baseline,3months,6months | 4 Peri implant marginal bone loss at baseline 3months 6 months

次要结局

  • 1 Implant stability(2 pink esthetic scores)

研究者

发起方
Dr. Arimanda Prithvi
申办方类型
Other [Self ]
责任方
Principal Investigator
主要研究者

Dr Arimanda Prithvi

Vishnu Dental College

研究点 (1)

Loading locations...

相似试验